140 results on '"Adams, Alexandra M."'
Search Results
2. Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma
3. Implementation of a novel peer review academy by Surgery and the Association of Women Surgeons
4. Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
5. SAGES/AHPBA guidelines for the use of minimally invasive surgery for the surgical treatment of colorectal liver metastases (CRLM)
6. Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer
7. Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
8. Minimally invasive versus open distal pancreatectomy: a matched analysis using ACS-NSQIP
9. Minimally invasive versus open hepatectomy for the resection of colorectal liver metastases: a systematic review and meta-analysis
10. ASO Visual Abstract: Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Non-metastatic Pancreatic Adenocarcinoma
11. Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival
12. The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy
13. The art of peer review: Guidelines to become a credible and constructive peer reviewer
14. Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention
15. Improved immunoassay sensitivity and specificity using single-molecule colocalization
16. ASO Visual Abstract: Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer
17. Tumor Lysate Particle Only Vaccine (TLPO) vs. Tumor Lysate Particle-Loaded, Dendritic Cell Vaccine (TLPLDC) to Prevent Recurrence in Resected Stage III/IV Melanoma Patients: Results of a Phase I/IIa Trial
18. A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
19. Tube Thoracostomy Complications in Patients With ARDS Requiring ECMO: Worse in COVID-19 Patients?
20. Theoretical framework and experimental validation of multiplexed analyte quantification using cross-reactive affinity reagents
21. Implementation of a novel peer review academy by Surgery and the Association of Women Surgeons
22. In vivo production of psilocybin in E. coli
23. Tube Thoracostomy Complications in Patients With ARDS Requiring ECMO: Worse in COVID-19 Patients?
24. Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis
25. ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination
26. Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials
27. "Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli".
28. The opportunity cost of operating: Infertility increases among female plastic surgeons
29. Minimally invasive approaches to intrahepatic cholangiocarcinoma
30. ASO Visual Abstract: Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer
31. Circulating Tumor DNA: Towards More Individualized Treatment for Patients with Resectable Colorectal Cancer
32. Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer
33. Hospital Treatment Intensity for Metastatic Colorectal Cancer: A Predictor of Improved Survival
34. Meeting the New Commission on Cancer Operative Standards: Where Do We Stand Now?
35. Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
36. Morbidity and Mortality of Non-pancreatectomy operations for pancreatic cancer: An ACS-NSQIP analysis
37. Chapter 80 - Investigational new drugs
38. Chapter 52 - Factorial design: design, measures, and classic examples
39. Chapter 57 - Adaptive: design, measures, and classic examples
40. Maximizing Benefit of Virtual Learning: Lessons From the Coronavirus Disease 2019 Pandemic
41. Minimally invasive versus open distal pancreatectomy: a matched analysis using ACS-NSQIP
42. Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats
43. American College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer
44. Meeting the New Commission on Cancer Operative Standards: Where Do We Stand Now?
45. Tube Thoracostomy Complications in Patients with ARDS Requiring Extracorporeal Membrane Oxygenation: Worse in COVID-19 Patients?
46. Tracheostomy Placement in Patients with Acute Respiratory Distress Syndrome Requiring Extracorporeal Membrane Oxygenation: Did COVID-19 Change Our Practice?
47. Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma
48. Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma
49. Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival.
50. Safety and efficacy of low-titer O whole blood resuscitation in a civilian level I trauma center
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.